Bolt Biotherapeutics, Inc. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 4.78K shares, a 91.27% increase year-over-year.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 0.00 shares.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-12-31 was 1.13K shares, a 61.70% decline year-over-year.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-09-30 was 0.00 shares.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 3.62K shares, a 60.45% decline from fiscal 2024.
- Bolt Biotherapeutics, Inc. stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 9.16K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 4.78K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 5.90K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | 3.62K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | 1.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 3.62K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 5.43K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | 2.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 5.43K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | |
| 2024-12-31 | 2.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 9.16K shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |